HAMSTER-TO-RAT HEART AND LIVER XENOTRANSPLANTATION WITH FK506 PLUS ANTIPROLIFERATIVE DRUGS
Noriko Murase(University of Pittsburgh), L Makowka, Minoru Tanabe(Tokyo Institute of Technology), L A Valdivia(University of Pittsburgh), Donald V. Cramer(University of Pittsburgh), Thomas E. Starzl(University of Pittsburgh Medical Center), Anthony J. Demetris(University of Pittsburgh Medical Center)
Cited by 151
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
|The Lancet|1984|1.3k
Production of α1,3-Galactosyltransferase-Deficient Pigs
|Science|2003|1.1k
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
|American Journal of Transplantation|2003|1.1k
Evolution of Liver Transplantation
|Hepatology|1982|887